BYNRAFT
LIVE

Serial Number

79413084

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Oct 31, 2024

Add to watchlist:

No watchlists yet
View on USPTO

BYNRAFT Trademark

Serial Number: 79413084 • Registration: 7805865

BYNRAFT is a trademark filed by NOVARTIS AG on October 31, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,165 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

October 31, 2024

Registration Date

May 27, 2025

Published for Opposition

April 8, 2025

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 25, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 25, 2026 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 26, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 27, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
May 27, 2025 R.PR
PUBLISHED FOR OPPOSITION
Apr 8, 2025 PUBO
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Apr 7, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 7, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 7, 2025 REAP
NOTICE OF PUBLICATION
Apr 2, 2025 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 13, 2025 CNSA
ASSIGNED TO EXAMINER
Mar 12, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 3, 2025 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 30, 2024 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 26, 2024 REPR